EICHOR
● Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Condition: Obesity · Cardiovascular Diseases · Sponsor: Eli Lilly and Company
About this study
The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 113 weeks.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (169)
| Central Phoenix Medical Clinic | Phoenix, Arizona, United States | — |
| Valley Clinical Trials, Inc. | Covina, California, United States | — |
| Neuro-Pain Medical Center | Fresno, California, United States | — |
| Valley Research | Fresno, California, United States | — |
| Collaborative Neuroscience Research, LLC | Los Alamitos, California, United States | — |
| Velocity Clinical Research, Westlake | Los Angeles, California, United States | — |
| Valley Clinical Trials, Inc. | Northridge, California, United States | — |
| Velocity Clinical Research, Panorama City | Van Nuys, California, United States | — |
| Chase Medical Research, LLC | Waterbury, Connecticut, United States | — |
| Indago Research & Health Center, Inc | Hialeah, Florida, United States | — |
| Clinical Neuroscience Solutions, Inc. dba CNS Healthcare | Jacksonville, Florida, United States | — |
| Clinical Neuroscience Solutions, Inc. | Orlando, Florida, United States | — |
+ 157 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.